Home / Report
Biosimilars Council works to ensure a positive environment for patient access to biosimilar medicines. Division of @AccessibleMeds | https://t.co/0jAeG0TOPj
Biosimilar availability may not be in its purview, but the @US_FDA is still thinking about ways to help the industry deal with the issue and support sector growth.
Read more: https://pink.pharmaintelligence.informa.com/PS143305/BsUFA-III-Reauthorization-Process-Begins-With-US-FDA-Considering-Staffing-Uptake-Issues
601 New Jersey Ave NW, Suite 850
Washington DC 20001
E: [email protected]
Sign up for our Newsletter
©2020 Biosimilars Council
Biosimilars Council is a division of the Association for Accessible Medicines.